The global age-specific incidence rate for early-onset chronic kidney disease (CKD) has increased by approximately 28.64% from 1990 to 2019, and it is projected to become the 5th leading cause of ...

Discover the five major risk factors for kidney disease, from daily habits to genetic predisposition, and learn the warning ...

Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...

Tolvaptan Slows Progression in Genetic Kidney Disease A real-world long-term analysis reveals the benefits of tolvaptan in slowing kidney function decline in autosomal dominant polycystic kidney ...

Polycystic kidney disease (PKD), a family of genetic disorders that causes clusters of cysts to form on the kidney, is among the most common genetic disorders, affecting some 500,000 people in the ...

Long-term tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD) yielded a 14% reduction in kidney function decline but had no influence on kidney growth.